Explore UAB

Planning on working in the COVID-19 research space? It will be important to prepare for the specific requirements for handling infectious materials. The Center for Disease Control makes it clear that research with the actual SARS-CoV2 virus must be performed in a BSL3 laboratory. This includes any culture involving cells isolated from, or exposed, to COVID-19+ patient tissues that may be permissive to virus replication. At this time, there are no definitive guidelines from the NIH or CDC regarding the BSL classification of COVID-19 sample-based research. Because these specimens pose a higher risk than standard agents found in BSL2 laboratories, investigators are expected to adopt more stringent BSL-3 practices and procedures, sometimes referred to as “BSL2+” or BSL2.5”.

To help investigators understand their options, the CCTS has compiled the following resource list: